Market Trends– category –
-
Biolinq’s Needle-Free Autonomous Wearable Biosensor, Shine™, Receives FDA De Novo Classification, Establishing New Device Category
EvoNexus USA Overview Biolinq, an EvoNexus graduate company, announced that its Shine™ device, a needle-free autonomous wearable biosensor, has received FDA De Novo classification. This classification creates a new regulatory category fo... -
Labman Develops Next-Gen POCT HPV Screening Device under EU ELEVATE Project: Rapid Detection of 14 HPV Strains and Two Biomarkers
News-Medical.net UK Overview Labman has developed a next-generation point-of-care (POCT) HPV screening device as part of the EU-funded ELEVATE project. This compact, portable instrument utilizes microfluidic 'lab-on-a-chip' technology to... -
Microfluidics Market Projected to Reach $37.2 Billion by 2030, Driven by POCT and Personalized Medicine
Menafn International Overview This article provides an overview of a market research report published by Menafn, forecasting the global microfluidics market to reach $37.2 billion by 2030. The growth is primarily fueled by increasing dem... -
Roche Secures EU CE Mark for Elecsys pTau217 Alzheimer’s and Elecsys IGRA TB Blood Tests
GlobeNewswire Switzerland Overview Roche announced that its Elecsys pTau217 blood test for Alzheimer's disease diagnosis and Elecsys IGRA TB test for latent tuberculosis infection have received EU CE mark certification. This approval, pa... -
FDA Clears Dexcom’s Stelo OTC Continuous Glucose Monitor for Non-Insulin Users Aged Two and Up
Prime Therapeutics - Portal USA Overview The FDA has granted over-the-counter (OTC) marketing authorization for Dexcom's Stelo Glucose Biosensor System, expanding its use to non-insulin users aged two and older. This marks the first OTC ... -
BIOSENSOR 2026 Conference Unveils Key Topics of Interest: Featuring Lab-on-a-Chip, Nanobiosensors, Proteomics for Cancer Cell Detection, and Single-Cell Analysis
BIOSENSOR 2026 - 7th International Congress on Biosensors Unknown Overview The 7th International Congress on Biosensors, BIOSENSOR 2026, has announced its key Topics of Interest ahead of the August 16, 2026, abstract submission deadline.... -
Global Summit on Biosensors and Bioelectronics to Convene in Chicago, September 2026: Discussing Nanotech, AI, and Wearable Devices
Global Scientific Forum USA Overview The "Global Summit on Biosensors and Bioelectronics" is scheduled for September 28-29, 2026, in Chicago, USA. This international conference will delve into cutting-edge technologies and future trends ... -
FDA Selects Dexcom as Inaugural Participant in Digital Health Pilot to Accelerate AI-Integrated Glucose Management
Healthcare Dive USA Overview The U.S. FDA has named Dexcom as the first participant in its new digital health pilot program, designed to streamline regulatory pathways for innovative devices. This initiative will exempt certain Dexcom di... -
California Nanotechnologies Reports 28% Revenue Increase to $917,854 in Q1 2027, Expands into Small Modular Reactor (SMR) Nuclear Energy Sector
California Nanotechnologies Corp. USA Overview California Nanotechnologies Corp. announced a 28% year-over-year revenue increase to $917,854 for Q1 2027, ending May 31, 2026. The company is strategically expanding its operations into the... -
China’s Nanometer Titania Market Forecast to Reach $939 Million by 2034, Driven by Cosmetics and Environmental Remediation, Growing at 7.8% CAGR
24ChemicalResearch China Overview This article summarizes a market research report by 24ChemicalResearch. China's nanometer titania (TiO2) market is projected to grow from $512.3 million in 2026 to $939 million by 2034, at a CAGR of 7.8%...
